Tripathi Satvik, Tabari Azadeh, Mansur Arian, Dabbara Harika, Bridge Christopher P, Daye Dania
Department of Radiology, Massachusetts General Hospital, Boston, MA 02114, USA.
Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA 02129, USA.
Diagnostics (Basel). 2024 Jan 12;14(2):174. doi: 10.3390/diagnostics14020174.
Pancreatic cancer is a highly aggressive and difficult-to-detect cancer with a poor prognosis. Late diagnosis is common due to a lack of early symptoms, specific markers, and the challenging location of the pancreas. Imaging technologies have improved diagnosis, but there is still room for improvement in standardizing guidelines. Biopsies and histopathological analysis are challenging due to tumor heterogeneity. Artificial Intelligence (AI) revolutionizes healthcare by improving diagnosis, treatment, and patient care. AI algorithms can analyze medical images with precision, aiding in early disease detection. AI also plays a role in personalized medicine by analyzing patient data to tailor treatment plans. It streamlines administrative tasks, such as medical coding and documentation, and provides patient assistance through AI chatbots. However, challenges include data privacy, security, and ethical considerations. This review article focuses on the potential of AI in transforming pancreatic cancer care, offering improved diagnostics, personalized treatments, and operational efficiency, leading to better patient outcomes.
胰腺癌是一种极具侵袭性且难以检测的癌症,预后较差。由于缺乏早期症状、特异性标志物以及胰腺位置具有挑战性,晚期诊断很常见。成像技术改善了诊断,但在标准化指南方面仍有改进空间。由于肿瘤异质性,活检和组织病理学分析具有挑战性。人工智能(AI)通过改善诊断、治疗和患者护理彻底改变了医疗保健。AI算法可以精确分析医学图像,有助于早期疾病检测。AI还通过分析患者数据以定制治疗方案在个性化医疗中发挥作用。它简化了行政任务,如医疗编码和文档记录,并通过AI聊天机器人为患者提供帮助。然而,挑战包括数据隐私、安全和伦理考量。这篇综述文章重点关注AI在改变胰腺癌护理方面的潜力,提供改进的诊断、个性化治疗和运营效率,从而带来更好的患者预后。
Diagnostics (Basel). 2024-1-12
J Multidiscip Healthc. 2024-8-15
Int J Mol Sci. 2025-5-29
Cureus. 2024-10-29
Diagnostics (Basel). 2024-9-29
Cancers (Basel). 2024-4-26
Proc IEEE Inst Electr Electron Eng. 2021-5
Curr Opin Gastroenterol. 2023-9-1
J Am Coll Radiol. 2023-9
Nat Biomed Eng. 2023-6
J Pers Med. 2023-6-5
Sci Rep. 2023-6-15